Cargando…
Tiotropium might improve survival in subjects with COPD at high risk of mortality
BACKGROUND: Inhaled therapies reduce risk of chronic obstructive pulmonary disease (COPD) exacerbations, but their effect on mortality is less well established. We hypothesized that heterogeneity in baseline mortality risk influenced the results of drug trials assessing mortality in COPD. METHODS: T...
Autores principales: | Burgel, Pierre-Régis, Paillasseur, Jean-Louis, Dusser, Daniel, Roche, Nicolas, Liu, Dacheng, Liu, Yufeng, Furtwaengler, Armin, Metzdorf, Norbert, Decramer, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061116/ https://www.ncbi.nlm.nih.gov/pubmed/24913266 http://dx.doi.org/10.1186/1465-9921-15-64 |
Ejemplares similares
-
Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality
por: Burgel, Pierre-Régis, et al.
Publicado: (2012) -
Identification of Clinical Phenotypes Using Cluster Analyses in COPD Patients with Multiple Comorbidities
por: Burgel, Pierre-Régis, et al.
Publicado: (2014) -
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients
por: Pahus, Laurie, et al.
Publicado: (2019) -
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial
por: Tashkin, Donald P, et al.
Publicado: (2015) -
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
por: Anzueto, Antonio, et al.
Publicado: (2015)